Prediction of the presence of insulin resistance using general health checkup data in Japanese employees with metabolic risk factors

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 1, 2014, Pages 38-48

  Takahara, Mitsuyoshi ^a   Katakami, Naoto ^a   Kaneto, Hideaki ^a   Noguchi, Midori ^b   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Health Support Promotion Section   (Japan)

Author keywords

General health checkup; Insulin resistance; Predictive performance

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE MODEL; FEMALE; HUMAN; INSULIN RESISTANCE; JAPAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR; WAIST CIRCUMFERENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; PHYSICAL EXAMINATION; RISK FACTORS; ROC CURVE; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84892991753     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.18622     Document Type: Article

References (36)

1. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus: The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. J Diabetes Invest, 2010; 1: 212-228
2. The Examination Committee of Criteria for the Metabolic Syndrome in Japan.: Definition and diagnostic criteria of the metabolic syndrome. J Japan Soc Intern Med, 2005; 94: 794-809 (in Japanese)
3. Wang H, Hu B, Feng B: Decreased Beta cell function and insulin sensitivity contributed to coronary artery disease in patients with normal glucose tolerance. J Atheroscler Thromb, 2012; 19: 806-813
4. Gotoh S, Doi Y, Hata J, Ninomiya T, Mukai N, Fukuhara M, Kamouchi M, Kitazono T, Kiyohara Y: Insulin resistance and the development of cardiovascular disease in a Japanese community: the Hisayama study. J Atheroscler Thromb, 2012; 19: 977-985
5. Yamamuro M, Yamamoto K, Kan H, Takashio S, Tayama S, Kaikita K, Hokimoto S, Sumida H, Sugiyama S, Ogawa H: Effects of a fixed combination of losartan with hydrochlorothiazide on glucose tolerance in hypertensive patients uncontrolled with angiotensin ii receptor blockers alone. J Atheroscler Thromb, 2013; 20: 238-244
6. Abe Y, Okada T, Iguchi H, Saito E, Kuromori Y, Iwata F, Hara M, Mugishima H, Kitamura Y: Association of changes in body fatness and fatty acid composition of plasma phospholipids during early puberty in Japanese children. J Atheroscler Thromb, 2012; 19: 1102-1109
7. Oka R, Yagi K, Sakurai M, Nakamura K, Nagasawa SY, Miyamoto S, Nohara A, Kawashiri MA, Hayashi K, Takeda Y, Yamagishi M: Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J Atheroscler Thromb, 2012; 19: 814-822
8. Uetani E, Tabara Y, Igase M, Kido T, Ochi N, Takita R, Kohara K, Miki T: Liver enzyme and adipocytokine profiles are synergistically associated with insulin resistance: the J-SHIPP study. J Atheroscler Thromb, 2012; 19: 577-584
9. Tamaki N, Ueno H, Morinaga Y, Shiiya T, Nakazato M: Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholester olemia. J Atheroscler Thromb, 2012; 19: 532-538
10. Arao T, Okada Y, Mori H, Nishida K, Tanaka Y: Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension. Endocr J, 2013; 60: 563-570
11. Miyauchi S, Matsuura B, Ueda T, Eguchi T, Tamaru M, Yamamoto S, Miyake T, Furukawa S, Abe M, Hiasa Y, Onji M: Interleukin-18 induces insulin resistance in the hyperthyroid state. Endocr J, 2013; 60: 449-455
12. Okita K, Iwahashi H, Kozawa J, Okauchi Y, Funahashi T, Imagawa A, Shimomura I: Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocr J, 2013; 60: 283-290
13. Mizuno Y, Harada E, Katoh D, Kashiwagi Y, Morikawa Y, Nakagawa H, Yoshimura M, Saito Y, Yasue H: Cardiac production of B-type natriuretic peptide is inversely related to the plasma level of free fatty acids in obese individuals-possible involvement of the insulin resistance. Endocr J, 2013; 60: 87-95
14. Takamura T, Misu H, Ota T, Kaneko S: Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. Endocr J, 2012; 59: 745-763
15. Yoo DE, Lee MJ, Oh HJ, Kim SJ, Shin DH, Yoo TH, Kang SW, Choi KH, Han DS, Han SH: Low circulating adiponectin levels are associated with insulin resistance in non-obese peritoneal dialysis patients. Endocr J, 2012; 59: 685-695
16. Ucak S, Basat O, Satir E, Altuntas Y: Evaluation of various insulin sensitivity indices in lean idiopathic hirsutism patients. Endocr J, 2012; 59: 291-296
17. Aizawa T, Yamada M, Katakura M, Funase Y, Yamashita K, Yamauchi K: Hyperbolic correlation between insulin sensitivity and insulin secretion fades away in lean subjects with superb glucose regulation. Endocr J, 2012; 59: 127-136
18. Oka R, Yagi K, Sakurai M, Nakamura K, Moriuchi T, Miyamoto S, Nohara A, Kawashiri MA, Takeda Y, Yamagishi M: Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. Endocr J, 2012; 59: 55-64
19. Yamada C, Moriyama K, Takahashi E: Association between insulin resistance and metabolic syndrome risk factors in Japanese. J Diabetes Invest, 2012; 3: 185-190
20. Morimoto A, Tatsumi Y, Deura K, Mizuno S, Ohno Y, Watanabe S: Impact of cigarette smoking on impaired insulin secretion and insulin resistance in Japanese men: The Saku Study. J Diabetes Invest, 2013; 4: 274-280
21. Mita T, Nakayama S, Abe H, Gosho M, Iida H, Hirose T, Kawamori R, Watada H: Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia. J Diabetes Invest, 2013; 4: 297-303
22. Yamada C, Moriyama K, Takahashi E: Optimal cut-off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non-diabetic Japanese subjects. J Diabetes Invest, 2012; 3: 384-387
23. Mitsuo R, Fukushima M, Taniguchi A, Nakai Y, Aoyama S, Takahashi Y, Tsuji H, Yabe D, Yasuda K, Kurose T, Kawakita T, Seino Y, Inagaki N: Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese. J Diabetes Invest, 2012; 3: 377-383
24. DeFronzo RA, Matsuda M: Reduced time points to calculate the composite index. Diabetes Care, 2010; 33: e93
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-419
26. Yamada C, Mitsuhashi T, Hiratsuka N, Inabe F, Araida N, Takahashi E: Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J Diabetes Invest, 2011; 2: 373-376
27. The Examination Committee of Criteria for 'Obesity Disease' in Japan. and Japan Society for the Study of Obesity.: New criteria for 'obesity disease' in Japan. Circ J, 2002; 66: 987-992
28. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, H. O and Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society: International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest, 2012; 3: 39-40
29. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I: Distribution of the Matsuda Index in Japanese healthy subjects. J Diabetes Invest, 2013; 4: 369-371
30. Japan Diabetes Society.: Treatment Guide for Diabetes 2012-2013, Bunkodo, Tokyo, 2012 (in Japanese)
31. Matsuzawa Y, Funahashi T, Nakamura T: The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb, 2011; 18: 629-639
32. Arai H, Ishibashi S, Bujo H, Hayashi T, Yokoyama S, Oikawa S, Kobayashi J, Shirai K, Ota T, Yamashita S, Gotoda T, Harada-Shiba M, Sone H, Eto M, Suzuki H, Yamada N: Management of type IIb dyslipidemia. J Atheroscler Thromb, 2012; 19: 105-114
33. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS: Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med, 2006; 355: 2631-2639
34. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 1999; 22: 1462-1470
35. Takahara M, Kaneto H, Shimomura I: Insulin Resistance can be Easily Estimated by Body Mass Index and Waist Circumference in a General Japanese Population. J Atheroscler Thromb, 2013; 20: 401-403
36. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I: Statistical reassessment of the association between waist circumference and clustering metabolic abnormalities in Japanese population. J Atheroscler Thromb, 2012; 19: 767-778